<DOC>
	<DOC>NCT00214331</DOC>
	<brief_summary>This protocol is a prospective, open-label, multicenter, population pharmacokinetic and pharmacodynamic study of selected anti-infective agents in pregnant women being treated for suspected or documented infections.</brief_summary>
	<brief_title>Pharmacokinetics and Pharmacodynamics and Selected Antibiotics During Pregnancy</brief_title>
	<detailed_description />
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Gentamicins</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<criteria>Women in their second or third trimester of pregnancy Women currently receiving treatment or whose physician has made the decision to start treatment with ciprofloxacin, azithromycin or gentamicin for a suspected or documented infection Of childbearing potential and who either have never been pregnant or whose most recent pregnancy ended 3 months previously (control group) Women greater than 3 months postpartum and currently breastfeeding (substudy) Women with significant gastrointestinal disease which may be expected to interfere with the absorption of the orally administered antiinfective agents</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>